Hematologic malignancies in the medical intensive care unit – Outcomes and prognostic factors

Hematology

Volumn 20, Issue 5, 2015, Pages 247-253

  Medić, Marijana Grgić ^a   Gornik, Ivan ^a,b   Gašparović, Vladimir ^a,b  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Hematologic malignancies; ICU; Mechanical ventilation; Mortality

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CANCER PROGNOSIS; FEMALE; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONINVASIVE VENTILATION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; AGED; HEMATOLOGIC NEOPLASMS; MIDDLE AGED; ODDS RATIO; PROGNOSIS; RISK FACTOR;

ADULT; AGED; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MORTALITY; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84929168380     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/1607845414Y.0000000206     Document Type: Article

References (39)

1. Brunet F, Lanore JJ, Dhainaut JF, Dreyfus F, Vaxelaire JF, Nouira S, et al. Is intensive care justified for patients with haematological malignancies? Intensive Care Med. 1990;16: 291–7.
2. Azoulay E, Recher C, Alberti C, Soufir L, Leleu G, Le Gall JR, et al. Changing use of intensive care for hematological patients: the example for hematological patients: the example of multiple myeloma. Intensive Care Med. 1999;25:1395–401.
3. Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med. 2003;31:104–12.
4. Cuthbertson BH, Rajalingham Y, Harrison S, McKirdy F. The outcome of haematological malignancy in Scottish intensive care units. J Intensive Care Soc. 2008;9:135–40.
5. Rees JKH, Gray RG, Wheatley K. Dose intensification in acute myleiod leukaemia: greater effectiveness at lower cost. Principal report of the medical research council’s AML9 study. Br J Haematol. 1996;94:89–98.
6. Azoulay E, Afessa B. The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med. 2006;32:3–5.
7. Hampshire PA, Welch CA, McCrossan LA, Francis K, Harrison DA. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care. 2009;13: R137.
8. Crawford SW, Petersen FB. Long-term survival from respiratory failure after marrow transplantation for malignancy. Am Rev Respir Dis. 1992;145:510–4.
9. Khassawneh BY, White P, Jr, Anaissie EJ, Barlogie B, Hiller FC. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest. 2002;121:185–8.
10. Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG. Outcome of recipients of bone marrow transplants who required intensive care unit support. Mayo Clin Proc. 1992;67:117–22.
11. Yau E, Rohatiner AZ, Lister TA, Hinds CJ. Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. Br J Cancer. 1992;64:938–42.
12. Owczuk R, Wujtewicz MA, Sawicka W, Wadrzyk A, Wujtewicz M. Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and nonsurvivors in intensive care unit. Support Care Cancer. 2005;13: 332–8.
13. Evison J, Rickenbacher P, Ritz R, Gratwohl A, Hoberthür C, Elasser S, et al. Intensive care unit admission in patients with haematological disease: incidence, outcome and prognostic factors. Swiss Med Wkly. 2002;131:681–6.
14. Lamia B, Hellot M, Girault C, Tamion F, Dachraoui F, Lenain P, et al. Changes in severity and organ failure scores as prognostic factors in oncohematological malignancy patients admitted to the ICU. Intensive Care Med. 2006;32:1560–8.
15. Kroschinsky F, Weise M, Illmer T, Haenel M, Bornhaeuser M, Hoeffken G, et al. Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med. 2002;28:1294–300.
16. Geerse DA, Span LF, Pinto-Sietsma SJ, van Mook WN. Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality. Eur J Intern Med. 2011;22:57–61.
17. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296–327.
18. Gasparovic V, Filipovic-Greie I, Merkler M, Pisl Z. Continuousrenal replacement therapy (CRRT) or intermittent hemodialysis (IHD)—what is the procedure of choice in critically ill patients? Ren Fail. 2003;25:855–62.
19. Azoulay E, Albertti C, Bronstain C, Leleu G, Moreau D, Recher C, et al. Improved survival in cancer patients requiring mechanical ventilatiory support: impact of noninvasive mechanical ventilator support. Crit Care Med. 2001;29:519–25.
20. Staudinger T, Stoiser B, Mullner M, Locker GJ, Laczika K, Knapp S, et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med. 2000;28:1322–8.
21. Depuydt PO, Benoit DD, Vendewoude K, Decruyenaere J, Colardyn F. Outcome in non-invasively and invasively ventilated hematologic patients with acute respiratory failure. Chest. 2004; 126:1299–306.
22. Lloyd-Thomas AR, Wright I, Liter TA, Hinds CJ. Prognosis of patients receiving intensive care for life-threatening medical complications of hematological malignancy. BMJ 1988;296: 1025–9.
23. Hinds CJ, Martin R, Quinton P. Intensive care for patients with medical complications of hematologic malignancy: is it worth it? Schweiz Med Wochenschr. 1998;128:1467–73.
24. Larche J, Azouley E, Fieux F, Mesnard L, Moreau D, Thiery G, et al. Improved survival of critically ill cancer patients with septic shock. Intensive Care Med. 2003;29:1688–95.
25. Bird GT, Farquhar-Smith P, Wigmore T, Potter M, Gruber PC. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 year study. Br J Anaesth. 2012;108:452–9.
26. Massion PB, Dive AM, Doyen C, Bulpa P, Jamart J, Bosly A, et al. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med. 2002;30:2260–70.
27. Price KJ, Cardenas-Turanzas M, Lin H, Roden L, Nigam R, Nates JL. Prognostic indicators of mortality of mechanically ventilated patients with acute leukemia in a comprehensive cancer center. Minerva Anestesiol. 2013;79:147–55.
28. Adda M, Coquet I, Darmon M, Thierry G, Schlemmer B, Azoulay E. Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Crit Care Med. 2008;36(10):2766–72.
29. Pene F, Aubron C, Azoulay E, Blot F, Thiery G, Raynard B, et al. Outcome of critically ill allogeneic hematopoietic stemcell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol. 2006;23:643–9.
30. Poletti V, Trisolini R, Tura S. Pulmonary disease in patients with hematologic malignancies. Sarcoidosis Vasc Diffuse Lung Dis. 2002;191:29–45.
31. Antonelli M, Conti G, Bufi M, Costa MG, Lappa A, Rocco M, et al. Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial. JAMA. 2000;283:235–41.
32. Hibert G, Gruson D, Vargas D, Valentino R, Gbikpi-Benissan G, Dupon M, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever and acute respiratory failure. N Engl J Med. 2001;344:481–7.
33. Gruson D, Hilbert G, Valentino R, Vargas F, Chene G, Bebear C, et al. Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltrates. Crit Care Med. 2000;28:2224–30.
34. Antonelli M, Conti G, Rocco M, Arcangeli A, Cavaliere F, Proietti R, et al. Noninvasive positive pressure ventilation vs conventional oxygen supplementation in hypoxemic patients undergoing diagnostic bronchoscopy. Chest. 2002;121:1149–54.
35. Namendys-Silva SA, Gonzales-Herrera MO, Garcia-Guillen FJ, Txcocano-Becerra J, Herrera-Gomez A. Outcome of critically ill patients with hematological malignancies. Ann Hematol. 2013; 92:699–705.
36. Molina R, Bernal T, Borges M, Zaragoza R, Bonastre J, Granada RM, et al. Ventilatory support in critically ill hematology patients with respiratory failure. Crit Care. 2012;16:R133.
37. Wermke M, Sheimanck S, Hoffken G, Ehninger G, Bornhauser M, Illmer T. Respiratory failure in patients undergoing allogeneic hematopoietic SCT-a randomized trial on early non-invasive ventilation based on standard care hematology wards. Bone Marrow Transplant. 2012;37:574–80.
38. Souza-Dantas VC, Salluh JI, Soares M. Impact of neutropenia on the outcomes of critically ill patients with cancer: a matched case-control study. Ann Oncol. 2011;22:2094–100.
39. Labar B, Bogdanić V, Nemet D, Mrsic M, Pavletic Z, Zupancic S, et al. Allogeneic BMT for AML in Zagreb. Bone Marrow Transplant. 1989;4:86–7.